Why the study?
Does ERAS reduce LOS, complications, and readmission rates in patients who have had THA or TKA?
Does ERAS reduce LOS, complications, and readmission rates in patients who have had THA or TKA?
Answers are grounded in this paper and cite their sources.
ERAS significantly reduces length of stay and complications in patients undergoing total hip or knee arthroplasty without impacting 30-day readmissions.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: